基质金属蛋白酶-2与颈动脉粥样硬化的研究进展
被引量:1
Progress of study on matrix metalloproteinase-2 with carotid atherosclerosis
摘要
基质金属蛋白酶-2(matrix metalloproteinase-2,MMP-2)又称白明胶酶A,它表达广泛,能够降解明胶、多种胶原和基底膜成分,对于平滑肌细胞的增殖和迁移起着重要作用.这些作用推动了颈动脉粥样硬化(carotid atherosclerosis,CAS)的形成和进展[1].本文将MMP-2及其与颈动脉粥样硬化关系的研究进展作如下综述.
出处
《中国脑血管病杂志》
CAS
2004年第11期521-525,共5页
Chinese Journal of Cerebrovascular Diseases
参考文献34
-
1[1]Li YY, Li L, Zielke HR, et al. Increased expression of 72-kd type Ⅳ collagenase (MMP-2) in human aortic atheroscleroticlesions. AmJ Pathol, 1996, 148: 121-128.
-
2[2]Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol, 1999, 43:42-51.
-
3[3]Huhtala P, Chow LT, Tryggvason K. Structure of the human type Ⅳ collagense gene. J Biol Chem, 1990, 265: 77-82.
-
4[4]Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells.Nature, 1994, 370: 61-65.
-
5[5]Esther E, Jack P, Cleutjens J, et al. Matrix metalloproteinase inhibition after myocardial infarction. Circ Res,2001, 89: 201-210.
-
6[6]Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase: inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type Ⅰ collagen generating the specific 3/4 and 1/4 length fragments. J Biol Chem, 1995, 270: 5872-5876.
-
7[7]Lauer-Fields JL, Tuzinski KA, Schimokawa KI, et al.Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinase. J Biol Chem, 2000, 275: 13282-13290.
-
8[8]Fernandez-Patron C, Stewart KG, Zhang Y, et al. Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res,2000, 87: 670-676.
-
9[9]Mach F, Schonbeck U, Fabunmi RP, et al. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent machanism: implications for tubule formation. Am J Pathol, 1999, 154: 229-238.
-
10[10]Nagashima H, Aoka Y, Sakomura Y, et al. Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall. J Vasc Surg, 2004, 39: 447-453.
同被引文献19
-
1[2]Chow AK,Cena J,Schulz R.Acute actions and novel targets of matrix metalloprotoinases in the heart and vascalature.Br J Phar-macology,2007,152:189-205.
-
2[3]Johnson JL.Matrix metalloprteinases:influence on smooth muscle cells and atherosclerotic plaque atability.Expert Bev Cardiovase Ther,2007,5:265-282.
-
3[4]Chen HH,Wang DL.Nitric oxide inhibits matrix metallopro-teinase-2 expression via the induction of activating transcription factor 3 in endothelial cells.Mol Pharmacol,2004,65:1130-1140.
-
4[5]Nyormoi O,Bar-Eli M.Transcriptional regulation of metastasis related genes in human melanoma.Clin Exp Metastasis,2003,20:251-263.
-
5[6]Xie TX,Wei DY,Liu MG,et al.Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis.Oncogene,2004,23:3550-3560.
-
6[7]Grote K,Flach I,htchtefeld M,et al.Mechanical stretch enhances mRNA expression and proenzylne release of nmtrix metal-loproteinase-2(MMP-2)via NAD(P)H oxidase-derived reactive oxygen species.Circ Res,2003,92:80-86.
-
7[8]Boyd PJ,Doyle J,Gee E,et al.Mitogen-activated protein kinase signaling regulates endothelial cell assembly into networks and the expression of MT1-MMP and MMP-2.Am J Physiol Cell Physiol,2005,288:C659-C668,
-
8[9]Ispanovic E,Haas TL.JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells.Am J Physiol Cell Physiol,2006,291:C579-588.
-
9[10]Mountain DJ,Singh M,Menon B,et al.Interleukin-1 increases expression and activity of matrix metalloproteinase-2 in cardiac microvascular endothelial cells:role of PKCα/β1 and MAPKs.Am J Physiol Cell Physiol,2007,292:C867-875.
-
10[11]Xie Z,Singh M,Singh K.Differential regulation of matrix metal-loproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta.J Biol Chem,2004,279:39513-39519.
二级引证文献6
-
1孙红军,李科民,王飞鸣,陈向民,梅庭芳.基质金属蛋白酶-9对急性冠状动脉综合征患者近期预后的判断价值[J].淮海医药,2009,27(5):377-379. 被引量:4
-
2孙春凤,黄国平,陈克平.基质金属蛋白酶-2的结构和功能[J].安徽医科大学学报,2013,48(3):330-332. 被引量:14
-
3冯秀元,汪玉宝,胡正清,徐广,高晓东.血清明胶酶与绝经后女性代谢综合征的关系[J].中国心血管病研究,2013,11(10):829-831.
-
4张璐,林新瑜.基质金属蛋白酶-2与皮肤病的研究进展[J].中国美容医学,2014,23(13):1127-1131. 被引量:2
-
5田甜,朱煌.MMP-2与近视关系的研究进展[J].中华眼视光学与视觉科学杂志,2014,16(8):510-512. 被引量:2
-
6钟丽华,孙超宇,曹雪,李馨,白秀萍,李学奇.急性冠状动脉综合征患者血清基质金属蛋白酶-2检测的临床意义[J].中国心血管病研究,2019,17(8):729-731. 被引量:1
-
1杨俊,张菲斐,杨海波,祁华琪,郭燕,黄振文.急性冠脉综合征患者外周血MMP-2、MCP-1的检测及意义[J].山东医药,2008,48(19):31-33. 被引量:2
-
2高毅,王宇,杨继震,黄宇琦.实验性肝纤维化过程中明胶酶A基因表达的动态变化[J].世界华人消化杂志,1999,7(11):1003-1004. 被引量:6
-
3李慧仙.128例脑梗死与颈动脉粥样硬化的相关性研究[J].云南医药,2009,30(1):78-80.
-
4缪应雷,欧阳钦,段丽平,李晓燕.明胶酶A及其抑制剂在溃疡性结肠炎活检肠黏膜的表达[J].中华消化内镜杂志,2004,21(1):45-46.
-
5李崇剑,徐耕,傅国胜,蔡思宇,单江.颈动脉粥样硬化超声标识及血清C-反应蛋白与冠心病的关系[J].中华心血管病杂志,2005,33(9):853-853. 被引量:10
-
6滕宗艳,陈康,张海金,宋志强,宋芳芳,高强,高延辉,周令望,陈炳卿.对急性冠脉综合征患者MMP-2水平的研究[J].心血管康复医学杂志,2013,22(6):546-549. 被引量:1
-
7何建方,刘江,钱福初,戴利成,童照威,周建方.慢性肝病患者血清MMP-2的变化及与肝纤维化的关系[J].现代实用医学,2005,17(11):696-697.
-
8李慎军,张胜兰.糖尿病肾病基底膜成分的改变及其与临床的联系[J].辽宁实用糖尿病杂志,2002,10(3):5-7. 被引量:2
-
9骆雷鸣,刘国树,李妍涵,刘文玲,石岩,齐薇薇,孙治军,盖鲁粤,杨庭树,鲁倩.不稳定性心绞痛患者循环血单核细胞产生明胶酶A、B的变化[J].中国循环杂志,2001,16(3):173-175. 被引量:1
-
10张志广,任建丽,闻淑军.Hp感染影响不同胃黏膜病变中MMP-2表达的相关性研究[J].天津医药,2008,36(12):923-925. 被引量:2